Prokidney (PROK) Construction in Progress (2021 - 2026)
Prokidney's (PROK) quarterly Construction in Progress came in at $19.3 million in Q1 2026, up 418.12% year-on-year from $3.7 million in Q1 2025, and up 31.42% on a QoQ basis from $14.7 million in Q4 2025.
Prokidney (PROK) Construction in Progress (2021 - 2026) Analysis & Trends
Prokidney (PROK) has 6 years of Construction in Progress data on file, last reported at $19.3 million in Q1 2026.
- On a quarterly basis, Construction in Progress rose 418.12% year-over-year to $19.3 million in Q1 2026; TTM through Mar 2026 was $19.3 million, a 418.12% increase from a year earlier, with the FY2025 full-year figure at $14.7 million, up 500.94% from the prior year.
- Construction in Progress for Q1 2026 stood at $19.3 million, up from $14.7 million in the prior quarter.
- Over the last five years, Construction in Progress for PROK reached as high as $19.3 million in Q1 2026 and fell as low as $1.0 million in Q3 2022.
- Historically, Construction in Progress has averaged $6.5 million across 5 years, with a median of $4.5 million in 2025.
- Across the five-year window, Construction in Progress surged 746.16% in 2023 and sank 79.64% in 2024, its largest moves.
- Year by year, Construction in Progress stood at $1.6 million in 2022, then soared by 441.57% to $8.7 million in 2023, then tumbled by 72.01% to $2.4 million in 2024, then soared by 500.94% to $14.7 million in 2025, then jumped by 31.42% to $19.3 million in 2026.
- Per Business Quant data, the three most recent Construction in Progress figures were $19.3 million in Q1 2026, $14.7 million in Q4 2025, and $10.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 137.45 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Prokidney | 96.00 Mn | 96.00 Mn | - | 19.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.33 Mn |
| Dec 31, 2025 | 14.71 Mn |
| Sep 30, 2025 | 10.17 Mn |
| Jun 30, 2025 | 4.53 Mn |
| Mar 31, 2025 | 3.73 Mn |
| Dec 31, 2024 | 2.45 Mn |
| Sep 30, 2024 | 3.56 Mn |
| Jun 30, 2024 | 1.19 Mn |
| Mar 31, 2024 | 9.08 Mn |
| Dec 31, 2023 | 8.74 Mn |
| Sep 30, 2023 | 8.49 Mn |
| Jun 30, 2023 | 5.86 Mn |
| Mar 31, 2023 | 3.24 Mn |
| Dec 31, 2022 | 1.61 Mn |
| Sep 30, 2022 | 1.00 Mn |
| Dec 31, 2021 | 351,000.00 |